Does BEVACIZUMAB Cause Diffuse large b-cell lymphoma recurrent? 13 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Diffuse large b-cell lymphoma recurrent have been filed in association with BEVACIZUMAB (JOBEVNE). This represents 0.0% of all adverse event reports for BEVACIZUMAB.
13
Reports of Diffuse large b-cell lymphoma recurrent with BEVACIZUMAB
0.0%
of all BEVACIZUMAB reports
0
Deaths
0
Hospitalizations
How Dangerous Is Diffuse large b-cell lymphoma recurrent From BEVACIZUMAB?
Of the 13 reports.
Is Diffuse large b-cell lymphoma recurrent Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BEVACIZUMAB. However, 13 reports have been filed with the FAERS database.
What Other Side Effects Does BEVACIZUMAB Cause?
Off label use (12,094)
Death (8,493)
Diarrhoea (4,911)
Disease progression (4,653)
Fatigue (4,572)
Nausea (4,357)
Hypertension (4,309)
Anaemia (3,221)
Vomiting (3,193)
Neutropenia (2,875)
What Other Drugs Cause Diffuse large b-cell lymphoma recurrent?
RITUXIMAB (1,359)
CYCLOPHOSPHAMIDE (1,007)
VINCRISTINE (957)
DOXORUBICIN (953)
PREDNISONE (738)
CYTARABINE (406)
DEXAMETHASONE (402)
ETOPOSIDE (375)
CISPLATIN (306)
GEMCITABINE (280)
Which BEVACIZUMAB Alternatives Have Lower Diffuse large b-cell lymphoma recurrent Risk?
BEVACIZUMAB vs BEVACIZUMAB-AWWB
BEVACIZUMAB vs BEVACIZUMAB-BVZR
BEVACIZUMAB vs BEVACIZUMAB-MALY
BEVACIZUMAB vs BEXAROTENE
BEVACIZUMAB vs BEYAZ